Similar articles

• Experience with ceftizoxime: an overall summary of clinical trials in Japan.

  Shimada J, Shimizu K. Shimada J, et al. J Antimicrob Chemother. 1982 Nov;10 Suppl C:311-26. doi: 10.1093/jac/10.suppl_c.311. J Antimicrob Chemother. 1982. PMID: 6296026 Clinical Trial. No abstract available.
• [Fundamental and clinical studies of ceftizoxime in pediatric infections (author's transl)].

  Ogawa A, Aso K, Miyachi Y, Nishikawa K, Yafuso M, Kuno K. Ogawa A, et al. Jpn J Antibiot. 1982 Jan;35(1):152-9. Jpn J Antibiot. 1982. PMID: 6279906 Japanese.
• [Ceftizoxime in the treatment of infective pathology in the elderly].

  Garotta F, Magni O, Meinardi G. Garotta F, et al. Boll Chim Farm. 1986 Dec;125(12):127S-131S. Boll Chim Farm. 1986. PMID: 3473994 Italian. No abstract available.
• Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

  Richards DM, Heel RC. Richards DM, et al. Drugs. 1985 Apr;29(4):281-329. doi: 10.2165/00003495-198529040-00001. Drugs. 1985. PMID: 3888599 Review.
• Ceftizoxime: a beta-lactamase-stable, broad-spectrum cephalosporin. Pharmacokinetics, adverse effects and clinical use.

  Neu HC. Neu HC. Pharmacotherapy. 1984 Mar-Apr;4(2):47-60. doi: 10.1002/j.1875-9114.1984.tb03313.x. Pharmacotherapy. 1984. PMID: 6326062 Review.